Novus Biologicals products are now on bio-techne.com

Immuno-Oncology

Unlocking the Potential of Biosimilars in Immuno-Oncology

By Jennifer Jones, M.S.

Read more about Unlocking the Potential of Biosimilars in Immuno-Oncology
Log in or register to post comments

Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy

By Victoria Osinski, PhD

Tags:

Chimeric Antigen Receptor

Tumor Microenvironment

Victoria Osinski

Read more about Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy
Log in or register to post comments

Tired T cells: Hypoxia Drives T cell Exhaustion in the Tumor Microenvironment

By Hunter Martinez

Read more about Tired T cells: Hypoxia Drives T cell Exhaustion in the Tumor Microenvironment
Log in or register to post comments

Synthetic Biotic Medicine as Immunotherapy Against Cancer: Evidence From Arginine-Producing Engineered Bacteria

By Jamshed Arslan, Pharm D, PhD

Tags:

Cancer Research

Checkpoint Blockade

Checkpoint Inhibitors

Immuno-oncology

Innate Immunity

Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy

By Victoria Osinski, PhD

Read more about Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy
Log in or register to post comments

Popular Products	Company Information	Support	Stay Connected
Antibodies Secondary Antibodies Isotype Controls Proteins and Peptides ELISA Kits Sample Size New Products	About Us Careers Novus Guarantee Contact Us Our Team	Technical Support FAQs Help Finding Antibodies Protocols

Visit our other sites

©2024 Novus Biologicals, All Rights Reserved.